Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
72 hedge funds and large institutions have $23.3M invested in Surgalign Holdings, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 28 closing their positions.
42% more call options, than puts
Call options by funds: $180K | Put options by funds: $127K
10% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 20
19% less funds holding
Funds holding: 89 → 72 (-17)
53% less capital invested
Capital invested by funds: $49.1M → $23.3M (-$25.8M)
61% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 28
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CLG
Cooperman Leon G
|
+$1.59M |
| 2 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
+$1.27M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.06M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$964K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$390K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAM
Krensavage Asset Management
New York
|
-$6.9M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.09M |
| 3 |
EP
Eversept Partners
New York
|
-$1.42M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$1.14M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.08M |
SRGA Hedge Fund Activity: Q4 2021 in Review
72 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2021, worth a combined $23.3M — down 53% from $49.1M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of SRGA and 11 opened new positions — a net loss of 17 holders — while 20 trimmed existing stakes and 18 added.
The largest buyer was Cooperman Leon G, adding an estimated $1.59M. The largest seller was Krensavage Asset Management, exiting entirely with an estimated $6.9M sold.
- 72 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2021, down from 89 in Q3 2021.
- Funds reported $23.3M of Surgalign Holdings, Inc. Common Stock stock for Q4 2021, down 53% quarter-over-quarter.
- 11 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2021 and 28 closed out, a net change of -17 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2021 was Cooperman Leon G, an estimated $1.59M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2021 was Krensavage Asset Management, an estimated $6.9M sold.
Based on aggregated 13F filings for Q4 2021.